Loading…
Loading…
Tender ID
Eligibility, documents, scope, Go/No-Go checksEligibility, required documents, scope of work and Go/No-Go checks for this tender, in one click.
Tender Value
Refer Docs
Closing Date
10 Nov 2026, 9:00 am4d left
Eligibility, documents, scope, Go/No-Go checksEligibility, required documents, scope of work and Go/No-Go checks for this tender, in one click.
COMMANDANT CHSC PUNE
COMMAND HOSPITAL (SC) PUNE-40
MS/02/DGLP/ECHS/PA-02 DRUGS
2026_ARMY_794861_1
MS/02/DGLP/ECHS/PA-02/DRUGS
Open Tender
Drugs and Pharmaceutical Products
Buy
30 days
CHSC PUNE
Please refer Tender documents.
5 documents required · 5 mandatory
₹0
Exempted
21 Oct 2026
21 Oct 2026
10 Nov 2026
22 Oct 2026
10 Nov 2026
22 Oct 2026
22 Oct 2026 - 9 Nov 2026
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount | GST % |
|---|---|---|---|---|---|---|
| 1DEFPROC -PA-02/DGLP/ECHS/2026-27 | ||||||
| 1.1 | AMLOTRIPTAN 12.5 MG TAB | 6,192 | No | - | - | - |
| 1.2 | ACECLOFENAC 100 MG TAB | 98,400 | No | - | - | - |
| 1.3 | ARIPIPRAZOLE 15 MG TAB | 22,440 | No | - | - | - |
| 1.4 | Aceclofenac SR 200 mg Tab | 73,200 | No | - | - | - |
| 1.5 | Atorvastatin 40 mg Tab | 2,29,200 | No | - | - | - |
| 1.6 | BETHANECOL CHLORIDE 25 MG TAB | 12,384 | No | - | - | - |
| 1.7 | BICALUTAMIDE 50 MG TAB | 11,640 | No | - | - | - |
| 1.8 | ACENOCOUMAROL 4 MG TAB | 23,280 | No | - | - | - |
| 1.9 | BRIVARACETUM 50 MG Tab | 1,38,000 | No | - | - | - |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.48 MB
Tendernotice_2.pdf
PDF • 0.18 MB
BOQ_891526.xls
BOQ • 0.87 MB
TECHSHEET.xls
Tender Documents • 0.07 MB
taxdetailsCHSC_GST.xls
Tender Documents • 0.03 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .